360 related articles for article (PubMed ID: 34757450)
1. Pre-operative radiomics model for prognostication in resectable pancreatic adenocarcinoma with external validation.
Healy GM; Salinas-Miranda E; Jain R; Dong X; Deniffel D; Borgida A; Hosni A; Ryan DT; Njeze N; McGuire A; Conlon KC; Dodd JD; Ryan ER; Grant RC; Gallinger S; Haider MA
Eur Radiol; 2022 Apr; 32(4):2492-2505. PubMed ID: 34757450
[TBL] [Abstract][Full Text] [Related]
2. Validation of Prognostic Radiomic Features From Resectable Pancreatic Ductal Adenocarcinoma in Patients With Advanced Disease Undergoing Chemotherapy.
Salinas-Miranda E; Khalvati F; Namdar K; Deniffel D; Dong X; Abbas E; Wilson JM; O'Kane GM; Knox J; Gallinger S; Haider MA
Can Assoc Radiol J; 2021 Nov; 72(4):605-613. PubMed ID: 33151087
[TBL] [Abstract][Full Text] [Related]
3. Delta Radiomic Features Predict Resection Margin Status and Overall Survival in Neoadjuvant-Treated Pancreatic Cancer Patients.
Wang K; Karalis JD; Elamir A; Bifolco A; Wachsmann M; Capretti G; Spaggiari P; Enrico S; Balasubramanian K; Fatimah N; Pontecorvi G; Nebbia M; Yopp A; Kaza R; Pedrosa I; Zeh H; Polanco P; Zerbi A; Wang J; Aguilera T; Ligorio M
Ann Surg Oncol; 2024 Apr; 31(4):2608-2620. PubMed ID: 38151623
[TBL] [Abstract][Full Text] [Related]
4. Correlation of transcriptional subtypes with a validated CT radiomics score in resectable pancreatic ductal adenocarcinoma.
Salinas-Miranda E; Healy GM; Grünwald B; Jain R; Deniffel D; O'Kane GM; Grant R; Wilson J; Knox J; Gallinger S; Fischer S; Khokha R; Haider MA
Eur Radiol; 2022 Oct; 32(10):6712-6722. PubMed ID: 36006427
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of CT Radiomic Features in Resectable Pancreatic Ductal Adenocarcinoma.
Khalvati F; Zhang Y; Baig S; Lobo-Mueller EM; Karanicolas P; Gallinger S; Haider MA
Sci Rep; 2019 Apr; 9(1):5449. PubMed ID: 30931954
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic ductal adenocarcinoma: a radiomics nomogram outperforms clinical model and TNM staging for survival estimation after curative resection.
Xie T; Wang X; Li M; Tong T; Yu X; Zhou Z
Eur Radiol; 2020 May; 30(5):2513-2524. PubMed ID: 32006171
[TBL] [Abstract][Full Text] [Related]
7. Whole-tumour evaluation with MRI and radiomics features to predict the efficacy of S-1 for adjuvant chemotherapy in postoperative pancreatic cancer patients: a pilot study.
Liang L; Ding Y; Yu Y; Liu K; Rao S; Ge Y; Zeng M
BMC Med Imaging; 2021 Apr; 21(1):75. PubMed ID: 33902469
[TBL] [Abstract][Full Text] [Related]
8. Development of a radiomics-based model to predict occult liver metastases of pancreatic ductal adenocarcinoma: a multicenter study.
Zhao B; Xia C; Xia T; Qiu Y; Zhu L; Cao B; Gao Y; Ge R; Cai W; Ding Z; Yu Q; Lu C; Tang T; Wang Y; Song Y; Long X; Ye J; Lu D; Ju S
Int J Surg; 2024 Feb; 110(2):740-749. PubMed ID: 38085810
[TBL] [Abstract][Full Text] [Related]
9. Survival prediction after upfront surgery in patients with pancreatic ductal adenocarcinoma: Radiomic, clinic-pathologic and body composition analysis.
Shi H; Wei Y; Cheng S; Lu Z; Zhang K; Jiang K; Xu Q
Pancreatology; 2021 Jun; 21(4):731-737. PubMed ID: 33678581
[TBL] [Abstract][Full Text] [Related]
10. Radiomics nomogram for the preoperative prediction of lymph node metastasis in pancreatic ductal adenocarcinoma.
Bian Y; Guo S; Jiang H; Gao S; Shao C; Cao K; Fang X; Li J; Wang L; Ma C; Zheng J; Jin G; Lu J
Cancer Imaging; 2022 Jan; 22(1):4. PubMed ID: 34991733
[TBL] [Abstract][Full Text] [Related]
11. Development and external validation of a radiomics combined with clinical nomogram for preoperative prediction prognosis of resectable pancreatic ductal adenocarcinoma patients.
Wang F; Zhao Y; Xu J; Shao S; Yu D
Front Oncol; 2022; 12():1037672. PubMed ID: 36518321
[TBL] [Abstract][Full Text] [Related]
12. A single center experience in resectable pancreatic ductal adenocarcinoma : the limitations of the surgery-first approach. Critical review of the literature and proposals for practice update.
Dumont R; Puleo F; Collignon J; Meurisse N; Chavez M; Seidel L; Gast P; Polus M; Loly C; Delvenne P; Meunier P; Hustinx R; Deroover A; Detry O; Louis E; Martinive P; Van Daele D
Acta Gastroenterol Belg; 2017; 80(4):451-461. PubMed ID: 29560639
[TBL] [Abstract][Full Text] [Related]
13. A machine learning model for the prediction of survival and tumor subtype in pancreatic ductal adenocarcinoma from preoperative diffusion-weighted imaging.
Kaissis G; Ziegelmayer S; Lohöfer F; Algül H; Eiber M; Weichert W; Schmid R; Friess H; Rummeny E; Ankerst D; Siveke J; Braren R
Eur Radiol Exp; 2019 Oct; 3(1):41. PubMed ID: 31624935
[TBL] [Abstract][Full Text] [Related]
14. Preoperative prediction of disease-free survival in pancreatic ductal adenocarcinoma patients after R0 resection using contrast-enhanced CT and CA19-9.
Li D; Peng Q; Wang L; Cai W; Liang M; Liu S; Ma X; Zhao X
Eur Radiol; 2024 Jan; 34(1):509-524. PubMed ID: 37507611
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a radiomics model of magnetic resonance for predicting liver metastasis in resectable pancreatic ductal adenocarcinoma patients.
Huang Y; Zhou S; Luo Y; Zou J; Li Y; Chen S; Gao M; Huang K; Lian G
Radiat Oncol; 2023 May; 18(1):79. PubMed ID: 37165440
[TBL] [Abstract][Full Text] [Related]
16. A systematic review of prognosis predictive role of radiomics in pancreatic cancer: heterogeneity markers or statistical tricks?
Gao Y; Cheng S; Zhu L; Wang Q; Deng W; Sun Z; Wang S; Xue H
Eur Radiol; 2022 Dec; 32(12):8443-8452. PubMed ID: 35904618
[TBL] [Abstract][Full Text] [Related]
17. An Automated Prognostic Model for Pancreatic Ductal Adenocarcinoma.
Vezakis I; Vezakis A; Gourtsoyianni S; Koutoulidis V; Polydorou AA; Matsopoulos GK; Koutsouris DD
Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761882
[TBL] [Abstract][Full Text] [Related]
18. Development of a CT radiomics nomogram for preoperative prediction of Ki-67 index in pancreatic ductal adenocarcinoma: a two-center retrospective study.
Li Q; Song Z; Li X; Zhang D; Yu J; Li Z; Huang J; Su K; Liu Q; Zhang X; Tang Z
Eur Radiol; 2023 Nov; ():. PubMed ID: 37938382
[TBL] [Abstract][Full Text] [Related]
19. Outcome prediction in resectable lung adenocarcinoma patients: value of CT radiomics.
Choe J; Lee SM; Do KH; Kim S; Choi S; Lee JG; Seo JB
Eur Radiol; 2020 Sep; 30(9):4952-4963. PubMed ID: 32356158
[TBL] [Abstract][Full Text] [Related]
20. Computed Tomography-based Radiomics Evaluation of Postoperative Local Recurrence of Pancreatic Ductal Adenocarcinoma.
He M; Chen X; Wels M; Lades F; Li Y; Liu Z; Jin Z; Xue H
Acad Radiol; 2023 Apr; 30(4):680-688. PubMed ID: 35906151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
